Sarepta Therapeutics, Inc. — Form D
Sarepta Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-02-28. The offering totals $400.0M, of which $400.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-02-28
- Form: D
- Accession: 0000904454-20-000249
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $400.0M
- Amount sold: $400.0M
- Investors: 1
- Date of first sale: 2020-02-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-361658
Issuer
- Name: Sarepta Therapeutics, Inc.
- CIK: 0000873303
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 215 FIRST STREET, CAMBRIDGE, MA, 02142
- Phone: 617-274-4000
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| RICHARD J BARRY | Director | CAMBRIDGE, MA |
| M. KATHLEEN BEHRENS | Director | CAMBRIDGE, MA |
| MICHAEL W BONNEY | Director | CAMBRIDGE, MA |
| MARY ANN W GRAY | Director | CAMBRIDGE, MA |
| Douglas S Ingram | Director | CAMBRIDGE, MA |
| JOHN C MARTIN | Director | CAMBRIDGE, MA |
| CLAUDE W NICAISE | Director | CAMBRIDGE, MA |
| HANS W WIGZELL | Director | CAMBRIDGE, MA |
| WILLIAM TYRONNE CIAMBRONE | Executive Officer | CAMBRIDGE, MA |
| ALEXANDER S CUMBO | Executive Officer | CAMBRIDGE, MA |
| David Tyronne Howton | Executive Officer | AUSTIN, TX |
| Douglas S Ingram | Executive Officer | CAMBRIDGE, MA |
| SANDESH TYRONNE MAHATME | Executive Officer | CAMBRIDGE, MA |
| GILMORE TYRONNE O'NEILL | Executive Officer | CAMBRIDGE, MA |
| WILLIAM W CIAMBRONE | Executive Officer | CAMBRIDGE, MA |
Other filings by this issuer (1)
More